Targeting amyloid-beta by glucagon-like peptide -1 (GLP-1) in Alzheimer's disease and diabetes

By Bak Ann Mosegaard   Egefjord Lærke   Gejl Michael   Steffensen Charlotte   Stecher Chalotte Willemann   Smidt Kamille   Brock Birgitte   Rungby Jørgen  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 10, 2011-10 ,pp. : 1153-1162

Informa Healthcare

Access to resources Recommend Favorite

Electrochemistry of Alzheimer Disease Amyloid Beta Peptides

By  

Current Medicinal Chemistry, Vol. 25, Iss. 33, 2018-10 ,pp. : 4066-4083

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging amyloid beta (Ab) peptide modulators for the treatment of Alzheimer's disease (AD)

By Lukiw Walter J  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 2, 2008-06 ,pp. : 255-271

Informa Healthcare

Access to resources Recommend Favorite

Reciprocal regulation of cholesterol and beta amyloid at the subcellular level in Alzheimer’s disease

By Posse de Chaves Elena  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 6, 2012-06 ,pp. : 753-764

NRC Research Press

Access to resources Recommend Favorite

beta-Amyloid Aggregation Inhibitors for the Treatment of Alzheimer Disease Dream or Reality?

By  

Mini Reviews in Medicinal Chemistry, Vol. 1, Iss. 2, 2001-07 ,pp. : 175-186

Bentham Science Publishers

Access to resources Recommend Favorite